01.11.2013
To the attention of healthcare professionals and patients treated with PEGASYS
Following information received by the National Agency for Medicines and Medical Devices (NAMMD) concerning potential presence on the Romanian pharmaceutical market of counterfeit cartons labelled Pegasys 180 μg/0.5 ml solution for injection, pre-filled syringe (peginterferon alfa-2a), the NAMMD hereby informs you on the need to visually inspect the product prior to administration, because of obvious differences between the counterfeited and the original Pegasys
download document …